ORIC Pharmaceuticals, Inc.
ORIC
$12.12
-$0.10-0.82%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 281.49M | 287.14M | 282.51M | 203.72M | 255.96M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.98M | 8.45M | 8.61M | 7.71M | 6.29M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 288.47M | 295.59M | 291.12M | 211.43M | 262.25M |
|
|
|||||
| Total Current Assets | 288.47M | 295.59M | 291.12M | 211.43M | 262.25M |
| Net Property, Plant & Equipment | 9.07M | 2.56M | 2.76M | 3.02M | 11.30M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 589.00K | 7.13M | 7.76M | 8.37M | 588.00K |
| Total Assets | 408.89M | 431.19M | 346.86M | 242.86M | 274.14M |
|
|
|||||
| Total Accounts Payable | 3.82M | 2.90M | 3.13M | 5.16M | 1.55M |
| Total Accrued Expenses | 13.26M | 13.98M | 11.65M | 9.24M | 20.12M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 3.33M | 3.30M | 3.27M | 3.21M | 3.18M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 20.42M | 20.18M | 18.05M | 17.62M | 24.85M |
|
|
|||||
| Total Current Liabilities | 20.42M | 20.18M | 18.05M | 17.62M | 24.85M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 4.11M | 4.09M | 4.81M | 5.50M | 6.17M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 24.53M | 24.27M | 22.86M | 23.12M | 31.02M |
|
|
|||||
| Common Stock & APIC | 1.08B | 1.07B | 952.96M | 812.32M | 805.52M |
| Retained Earnings | -692.24M | -661.74M | -629.15M | -592.80M | -562.77M |
| Treasury Stock & Other | 786.00K | 615.00K | 187.00K | 209.00K | 379.00K |
| Total Common Equity | 384.36M | 406.92M | 324.00M | 219.74M | 243.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 384.36M | 406.92M | 324.00M | 219.74M | 243.12M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 384.36M | 406.92M | 324.00M | 219.74M | 243.12M |
|
|
|||||